Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting-Reference-Cited by-同舟云学术

Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting

Published:2013-06-04 Issue:1 Volume:13 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Athanasakis Kostas,Petrakis Ioannis,Karampli Eleftheria,Vitsou Elli,Lyras Leonidas,Kyriopoulos John

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2377-13-56.pdf

Reference25 articles.

1. O’ Connor A: Neuropathic pain; quality of life impact, costs and cost effectiveness of therapy. PharmacoEcon. 2009, 27 (2): 95-112.

2. Toth C: Substitution of Gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Med. 2010, 11: 456-465.

3. Rodriguez MJ, Diaz S, Vera–Llonch M, Dukes E, Rejas J: Cost – effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post – herpetic neuralgia. Curr med res opin. 2007, 23 (10): 2585-2596.

4. Dubinsky RM, Kabbany H, El-Chami Z, Butwell C, Ali H: Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the quality standards subcommittee of the American academy of neurology. Neurology. 2004, 63: 959-965.

5. Kost RG, Straus SE: Postherpetic neuralgia: pathogenesis, treatment and prevention. N Engl J Med. 1996, 335: 32-42.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in anti-neuropathic medications turnover in Iraq;Journal of Pharmaceutical Health Services Research;2023-10-25

2. Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece;Value in Health Regional Issues;2023-07

3. Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis;Osteoarthritis and Cartilage;2023-02

4. A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy;Expert Opinion on Pharmacotherapy;2022-01-27

5. Perioperative Pain Management in Total Knee Arthroplasty;Essentials of Cemented Knee Arthroplasty;2022